Product Name:8-Chloro-2-(methylthio)pyrimido[5,4-d]pyrimidine

IUPAC Name:8-chloro-2-(methylsulfanyl)pyrimido[5,4-d][1,3]diazine

CAS:176637-10-8
Molecular Formula:C7H5ClN4S
Purity:95%+
Catalog Number:CM167362
Molecular Weight:212.66

Packing Unit Available Stock Price($) Quantity
CM167362-250mg in stock ƛǶũ
CM167362-500mg in stock ȐŵȐ
CM167362-1g in stock ŵȺŵ
CM167362-5g 1-2 Weeks ƛƃũũ
CM167362-10g 1-2 Weeks ƿȐũƃ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:176637-10-8
Molecular Formula:C7H5ClN4S
Melting Point:-
Smiles Code:CSC1=NC=C(N=CN=C2Cl)C2=N1
Density:
Catalog Number:CM167362
Molecular Weight:212.66
Boiling Point:
MDL No:MFCD00227587
Storage:Store at 2-8°C.

Column Infos

Zongertinib
Boehringer’s zongertinib shows encouraging efficacy and tolerability profile in previously treated HER2 mutated lung cancer patients.
Zongertinib (also known as BI 1810631) is an investigational oral HER2-specific tyrosine kinase inhibitor (TKI) that is being developed as a potential treatment for HER2 mutated non-small cell lung cancer (NSCLC). Zongertinib was granted FDA Fast Track Designation in 2023, then in 2024 it was granted Breakthrough Therapy Designation by the U.S. FDA and China CDE for the treatment of adult patients with advanced NSCLC whose tumors have activating HER2 mutations, and who have received a prior systemic therapy.

Related Products